OrthopedicsThisWeek "At that first meeting we said that stem cell commercialization was imminent and that sales within five years would reach $100 million. Today, five stem cell branded products are on the market, sales this year will likely exceed our estimates from five years ago and, we estimate, one in ten surgeons in the United States has started employing stem cells therapeutically. At this pace, by 2015, virtually every surgeon in the United States will be incorporating stem cells in either autologous, allograft or cultured forms into their practices."
Key topics to look for at...
